Public Company News

HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101

TAIPEI and SHANGHAI and SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark Office (USPTO). Titled"E...

2025-10-21 19:00 1781

CAAS Introduces Rear-Wheel Active Steering Technology to Upper Mass-Market EVs in China

WUHAN, China, Oct. 21, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier inChina, today announced that with the rapid growth of automotive technological innovation, CAAS' subsidiary, Jingzhou Heng...

2025-10-21 18:00 1046

Baidu to Report Third Quarter 2025 Financial Results on Nov 18, 2025

BEIJING, Oct. 21, 2025 /PRNewswire/ -- Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the Third Quarter 2025 endedSeptember...

2025-10-21 17:00 1314

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

GOTHENBURG, Sweden, Oct. 21, 2025 /PRNewswire/ -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's ...

2025-10-21 14:45 1293

TDK and Gelion Establish Full Collaboration Agreement

To advance Sulfur battery technology anticipated to be transformational for the industry SYDNEY, Oct. 21, 2025 /PRNewswire/ -- Gelion plc (AIM: GELN), the global energy storage innovator, is delighted, further to its announcement on16 October 2025, to announce that the Tier One battery manufactu...

2025-10-21 14:00 1456

Xtep Launches Inaugural X-RUN CAMP for The Standard Chartered Heritage Marathon Hanoi in Vietnam

HANOI, Vietnam, Oct. 21, 2025 /PRNewswire/ -- As the strategic technology partner and exclusive gear sponsor of The Standard Chartered Heritage Marathon Hanoi, Xtep proudly supported the official launch of the SCHM X-RUN CAMP, held onOctober 19, 2025. Co-hosted by Xtep and Standard Chartered, the...

2025-10-21 11:27 1712

Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy

TAIPEI and SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system. DeepMind re...

2025-10-21 10:49 1163

Trinasolar and Mestron Energy Ink MOU to Strengthen Malaysia's National Energy Transition Roadmap Goals

Partnership to supply 50MW of Vertex N-type modules for renewable projects acrossMalaysia. SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- Trinasolar, a global leader in smart photovoltaic (PV) and energy storage solutions, has signed a memorandum of understanding (MoU) with Mestron Energy, a specialis...

2025-10-21 10:00 1650

Orbbec Captures 72% of Korea's Mobile Robot 3D Vision Market, New Report Shows

SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- Global market research firm Interact Analysis has released its3D Vision for South Korean Mobile Robots report, revealing that Orbbec hol...

2025-10-21 10:00 1225

SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and co...

2025-10-21 09:20 1256

Investor Conference Call and Webcast on Shaakichiuwaanaan Project - Lithium-Only Feasibility Study Results

PMET Resources President and CEO Ken Brinsden to host an investor call MONTREAL and SYDNEY, Oct. 21, 2025 /PRNewswire/ -- PMET Resources Inc. (the "Company" or "PMET") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to advise that it will host a live investor teleconference and webca...

2025-10-21 05:45 901

PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project

Unlocking Shaakichiuwaanaan's maiden Mineral Reserve and a key step towards final mine authorisation MONTREAL, Oct. 21, 2025 /PRNewswire/ -- October 21, 2025 – Sydney, Australia Highlights * Robust CV5 lithium-only Feasibility Study ("FS") completed on the Shaakichiuwaanaan Project (Project) ...

2025-10-21 05:45 836

Eason Technology Limited Received NYSE American Non-Compliance Letter

HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:DXF

2025-10-21 04:59 2118

The Generation Essentials Group Reports on Half Year Performance with a ~160% Increase in Revenue

* TGE Achieved ~160% Increase in Revenue * Hospitality arm's revenue increased by over 60% * Total Net Income Surged over 70% to US$61.0 million (non-GAAP adjusted) * Total Assets amounted to US$1.25 billion (US$25.7/share) * Net asset value amounted to US$841 million (US$17.3/share) PARIS...

2025-10-20 20:45 2194

SM Investments certified as a Great Place to Work® in 2025

PASAY CITY, Philippines , Oct. 20, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments), the parent company of the SM group, has been certified as a Great Place to Work for 2025 by the global authority on workplace culture, Great Place to Work®. 

2025-10-20 20:45 1347

HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025

Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stag...

2025-10-20 19:00 1357

IBM and Groq Partner to Accelerate Enterprise AI Deployment with Speed and Scale

Partnership aims to deliver faster agentic AI capabilities through IBM watsonx Orchestrate and Groq technology, enabling enterprise clients to take immediate action on complex workflows ARMONK, N.Y. and MOUNTAIN VIEW, Calif., Oct. 20, 2025 /PRNewswire/ -- IBM (NYSE:IBM

2025-10-20 18:09 1133

SKF at COP30: The world can't afford friction - it's time to scale what works

GOTHENBURG, Sweden, Oct. 20, 2025 /PRNewswire/ -- SKF will be attending COP30, held in Belém,Brazil in November 2025, to drive systemic change and progress through collaboration. A resilient industry demands open, systematic collaboration. SKF sees friction every day, in mindsets, metrics, and b...

2025-10-20 17:54 909

Tiger Brokers (Hong Kong) Sponsors CFA Institute Research Challenge -- Hong Kong Local Final for the First Time, Introducing the "Star Presenter" Award

HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Tiger Brokers (Hong Kong) Global Limited ("Tiger Brokers (Hong Kong)") is proud to announce its inaugural sponsorship of the 2025–2026 CFA Institute Research Challenge — Hong Kong Local Final, underscoring the firm's commitment to talent development, profe...

2025-10-20 17:40 1739

The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC

* After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to 0.62; two-sided P<0.0001). * OS was significantly longer with sac-TMT than with chemotherapy (H...

2025-10-20 17:06 1309
1 ... 77787980818283 ... 1670